PDK4 and metabolic dysfunction-associated steatotic liver disease: On the other hand, our results for PKLR and PDK4 appear to indicate a beneficial effect of TUG-891 on hepatic glucose metabolism in the context of the development of steatosis, as PKLR and PDK4 were shown to aggravate NAFLD [42, 43].